Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
A Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastatic Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Safety, Tolerability and Pharmacokinetics of Nivolumab in Chinese Subjects With Previously Treated Advanced or Recurrent Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dose-escalation Study of Birinapant and Pembrolizumab in Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of INCB053914 in Subjects With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Itacitinib Combined With INCB024360 and/or Itacitinib Combined With INCB050465 in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Registry Study for Personalized Cancer Therapy
- Status
- COMPLETED
- Phase
- N/A
A Study of Afatinib in Patients With Advanced Cancer With Changes in the HER Gene
- Status
- COMPLETED
- Phase
- PHASE2
MEDI9447 Alone and in Combination With MEDI4736 in Adult Participants With Select Advanced Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1